14 results
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... ICU The BLUE-protocol ... #BLUE #protocol ... #Algorithm #Dyspnea ... #Pulmonary #Ultrasound
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... ICU The BLUE-protocol ... combines signs, associates ... #Algorithm #Dyspnea ... #Pulmonary #Ultrasound
â–º
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... ICU The BLUE-protocol ... combines signs, associates ... The A-profile associates ... dyspnea-criticalcare-pulmonary-algorithm-pocus
â–º
POCUS Lung Algorithm for the Use of Ultrasound in the Evaluation of Dyspnea 

#Diagnosis #Management #CriticalCare
POCUS Lung Algorithm ... Ultrasound in the Evaluation ... POCUS #Dyspnea #Algorithm ... #Ddxof #Lung #Pulmonary
FALLS protocol - POCUS evaluation in shock

The FALLS-protocol is an ultrasound evaluation of patients with acute
FALLS protocol - ... POCUS evaluation ... shock The FALLS-protocol ... of the pleura, lungs ... #Shock #Algorithm
Point of Care Ultrasound Fluid Resuscitation Guide (using IVC and lung ultrasound)

Source Article: https://www.ncbi.nlm.nih.gov/pubmed/26475100

#IVFluid #Resuscitation #Algorithm
(using IVC and lung ... Resuscitation #Algorithm ... #Protocol #POCUS ... #Ultrasound #Lung ... #IVC #Pulmonary
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment algorithms ... Chronic Obstructive Lung ... limitation, further evaluation ... LAMA: long-acting ... #Management #Pulmonary
Causes of Pulmonary Hypertension - Differential Diagnosis Algorithm
Pulmonary Arterial Hypertension
 • Idiopathic
 • Associated with:
Causes of Pulmonary ... Pulmonary Arterial ... Idiopathic • Associated ... • Valvular Lung ... • Interstitial Lung
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
of interstitial lung ... disease (ILD)-associated ... systemicsclerosis #SSc #pulmonary ... management #treatment #algorithm
Pulmonary Nodule
Evaluation is guided by nodule size & assessment of probability of malignancy. In addition is
Evaluation is guided ... diameter are called lung ... characteristics associated ... with lung malignancy ... components are associated